![(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, min. 98%,(11aR)-10,11,12,13-四氢-5-羟基-3,7-二-9-菲基-二茚并[7,1-de:1',7'-fg][1,3,2]二氧磷杂八环-5-氧化物 , min. 98%](https://static.jkchemical.com/Structure/208/2081538.png)
(11aR)-10,11,12,13-四氢-5-羟基-3,7-二-9-菲基-二茚并[7,1-de:1',7'-fg][1,3,2]二氧磷杂八环-5-氧化物 , min. 98%
(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, min. 98%
分子式: C??H??O?P
分子量: 666.70
纯度: min. 98%
| 包装 | 库存 | 价格 | |
|---|---|---|---|
暂无数据 | |||
推荐产品
基本信息
安全信息
化学和物理性质
产品描述
Technical Notes:
1.Catalytic as ymmetric homo- 1 ,3 -dipolar cycload ditions of azomethine ylides: diastereo and enantios elective s ynthesis ofimidazolidines
2.Enantios elective construction of the biologically significant dibenzo1 , 4diazepine scaffold via organocatalytic as ymmetric three component reactions
3.Enantios elective construction of the biologically important cyclopenta1 , 4diazepine framework enabled by asymmetric catalysis by chiral spiro-phos phoric acid.
4.Triply hydrogen- bond- directed enantioselective ass embly of pyrrolobenzo-1 ,4-diazine skeletons with quaternary stereocenters.
